Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

2021202 citationsJournal Articlebronze Open Access

Authors

Jack F. Shern · National Institutes of Health

Joanna Selfe · Institute of Cancer Research

Elisa Izquierdo · Institute of Cancer Research

Rajesh Patidar · National Institutes of Health

Hsien-Chao Chou · National Institutes of Health

Young Song · National Institutes of Health

Marielle E. Yohe

Abstract

This is the largest genomic characterization of clinically annotated rhabdomyosarcoma tumors to date and provides prognostic genetic features that refine risk stratification and will be incorporated into prospective trials.

Topics & Keywords

Sarcoma Diagnosis and Treatment Tumors and Oncological Cases CAR-T cell therapy research

Publication Details

Published in: Journal of Clinical Oncology

Volume 39, Issue 26, pp. 2859-2871

DOI: 10.1200/jco.20.03060

Field-Weighted Citation Impact: 21.72

Command Palette

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Authors

Abstract

Topics & Keywords

Publication Details